Cytek Biosciences (NASDAQ: CTKB) is a life sciences instrumentation company that develops and sells full-spectrum flow cytometry systems used in biological research and clinical applications. The company generates revenue through instrument sales and recurring streams from reagents, consumables, and service contracts tied to its installed base. The filing excerpts provided do not contain sufficient detail to characterize Cytek's market position, segment revenue breakdown, customer concentration, geographic mix, leadership, or founding history with the specificity required for a fully grounded description. Based solely on the available filing content, the business centers on proprietary flow cytometry technology sold to research institutions and clinical laboratories, with a recurring-revenue component that depends on continued instrument adoption and consumable pull-through from that installed base.

Revenue model

The filing excerpts do not provide sufficient revenue model detail to report specific figures or segment percentages.

Products and services

Full-spectrum flow cytometry instruments; reagents and consumables; service contracts. Specific product names are not supported by the available filing excerpts.

Customers and end markets

Biological research institutions and clinical laboratories. Customer concentration data is not supported by the available filing excerpts.

Value-chain role

Instrument manufacturer and consumable supplier to research and clinical end users.

Geographic exposure

Geographic revenue mix is not supported by the available filing excerpts.

Source: SEC 10-K, filed 2026-02-26

Industry: Laboratory Analytical Instruments Peers: 10X Genomics Inc Adaptive Biotechnologies Corp Neogenomics Inc Azenta Inc Medpace Holdings Inc Pacific Biosciences of California Inc NS Wind Down Co., Inc. Sotera Health Co Thermo Fisher Scientific Inc